Climb Bio (CLYM) director receives stock options on 40,000 common shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Climb Bio, Inc. director Kimberlee C. Drapkin received a grant of stock options covering 40,000 shares of Common Stock. The options have an exercise price of $10.55 per share and expire on June 4, 2036. Following this grant, she holds options on 40,000 shares directly. The options will vest on the earlier of June 5, 2027 or the date immediately prior to the next annual meeting of stockholders, subject to her continued service through that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Drapkin Kimberlee C
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 40,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 40,000 options
Exercise price: $10.55 per share
Underlying shares: 40,000 shares
+3 more
6 metrics
Option grant size
40,000 options
Stock Option (Right to Buy) granted to director
Exercise price
$10.55 per share
Exercise price of stock options
Underlying shares
40,000 shares
Common Stock underlying the options
Expiration date
June 4, 2036
Option expiration
Post-grant holdings
40,000 derivative shares
Total options held after transaction
Vesting date trigger
June 5, 2027 or before next annual meeting
Earlier of those dates, subject to continued service
Key Terms
Stock Option (Right to Buy), Common Stock, exercise price, annual meeting of stockholders, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)"
Common Stock financial
"underlying_security_title": "Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price": "10.5500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders financial
"prior to the date of the next annual meeting of stockholders"
continued service financial
"subject to the reporting person's continued service through such date"
FAQ
What insider transaction did Climb Bio (CLYM) report for Kimberlee C. Drapkin?
Climb Bio reported that director Kimberlee C. Drapkin received stock options on 40,000 shares of Common Stock. These options were granted as compensation, not bought on the open market, and represent a new equity incentive tied to her ongoing service.
What is the exercise price and term of the new Climb Bio (CLYM) stock options?
The granted stock options have an exercise price of $10.55 per share and expire on June 4, 2036. This gives the director a long-dated right to buy Climb Bio Common Stock at that fixed price if vesting conditions are met.
When do Kimberlee Drapkin’s Climb Bio (CLYM) stock options vest?
The options vest on the earlier of June 5, 2027 or the date immediately before Climb Bio’s next annual stockholder meeting. Vesting is conditioned on Drapkin’s continued service with the company through that applicable vesting date.